Notably, the PI3K-AKT pathway, a key cancer-related signaling pathway in RB tumorigenesis, is dysregulated and its activator, spleen tyrosine kinase (SYK), is significantly upregulated in retinal organoids, which could be the basis for the development of potential drugs targeting SYK (9). This evidence concerns the gene SYK and cancer.